Table 1 Clinical and blood pressure characteristics of participants not using blood pressure-lowering lowering medications
NT | WH | MH | SH | |
|---|---|---|---|---|
(n = 194) | (n = 68) | (n = 38) | (n = 154) | |
Male sex, n (%) | 86 (44) | 36 (53) | 22 (58) | 85 (55) |
Age, years | 42.2 ± 15.6 | 45.7 ± 16.7 | 46.8 ± 15.2 | 47.1 ± 14.5* |
Body mass index, k/m2 | 27.0 ± 4.2 | 27.6 ± 4.3 | 27.5 ± 3.3 | 28.8 ± 11.4 |
Hypolipemiant med, n (%) | 7 (4) | 4 (6) | 2 (5) | 7 (5) |
Antidiabetic med, n (%) | 8 (4) | 3 (4) | 0 (0) | 8 (5) |
Physical activity, n (%) | 63 (33) | 26 (38) | 12 (32) | 43 (28) |
Current smoking, n (%) | 2 (1) | 0 (0) | 1 (3) | 6 (4) |
Office SBP, mmHg | 120.8 ± 10.3 | 140.2 ± 12.4* | 124.7 ± 10.2† | 144.5 ± 16.9*‡ |
Office DBP, mmHg | 77.4 ± 7.6 | 89.5 ± 8.9* | 82.4 ± 7.4*† | 98.1 ± 10.9*†‡ |
Office MAP, mmHg | 91.9 ± 7.1 | 106.4 ± 6.0* | 96.5 ± 7.5*† | 113.6 ± 10.3*†‡ |
24 h SBP, mmHg | 113.5 ± 7.7 | 118.0 ± 6.1* | 126.9 ± 9.2*† | 129.7 ± 9.6*† |
24 h DBP, mmHg | 70.3 ± 5.9 | 73.6 ± 4.4* | 82.1 ± 5.4*† | 85.8 ± 6.8*†‡ |
24 h MAP, mmHg | 84.7 ± 5.6 | 88.4 ± 3.6* | 97.1 ± 5.0*† | 100.4 ± 6.6*†‡ |
Daytime SBP, mmHg | 116.3 ± 7.8 | 121.1 ± 7.4* | 130.0 ± 8.8*† | 133.0 ± 9.3*† |
Daytime DBP, mmHg | 73.3 ± 6.5 | 76.4 ± 5.3* | 84.9 ± 6.6*† | 89.1 ± 7.6*†‡ |
Daytime MAP, mmHg | 87.6 ± 6.0 | 91.3 ± 4.8* | 99.9 ± 5.6*† | 103.7 ± 7.0*†‡ |
Nighttime SBP, mmHg | 108.9 ± 9.2 | 113.0 ± 7.4 | 121.2 ± 12.1*† | 123.2 ± 15.2*† |
Nighttime DBP, mmHg | 65.2 ± 6.8 | 69.1 ± 5.3* | 77.1 ± 6.3*† | 79.9 ± 8.6*† |
Nighttime MAP, mmHg | 79.8 ± 6.8 | 83.7 ± 4.9* | 91.8 ± 7.2*† | 94.3 ± 9.5*† |